Indian scientists have developed a blood test using metabolomics and AI to detect up to 30 cancers early with high accuracy. The non-invasive, cost-effective test could transform cancer screening, especially in low-resource settings.

In a groundbreaking development, Indian researchers have created a noninvasive blood test capable of detecting up to 30 types of cancer in early stages. Using serum metabolomics, the test analyzes over 8,000 metabolites in the blood, chemical changes that occur subtly as cancer develops.

Led by Dr.Nagarkar from a Nashik-based oncology center, the study involved 6,445 participants, including 2,831 untreated cancer patients. Unlike conventional tests that search for tumor DNA, this method detects broader metabolic shifts, making it more sensitive in early detection.

Backed by machine learning and mass spectrometry, the test showed consistent accuracy across age and gender groups. With larger trials underway, experts believe this test could revolutionize cancer screening in resource-limited settings.

(Source:https://drugtodayonline.com/medical-news/news-topic/23437-indian-reserachers-develop-breakthrough-blood-test-capable-of-detecting-30-cancers-early-with-98-accuracy#google_vignette )